Navigation Links
UPDATE: Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
Date:3/23/2010

PHILADELPHIA, March 23 /PRNewswire/ -- The Superior Court of Pennsylvania has reinstated an appeal filed by John R. DePhillipo, former Chief Executive Officer of GeneLink Biosciences, (GNLK:OB) and his wife Maria. The appeal had been dismissed by an order from the same court on February 18, 2010. The Superior Court also ordered "The Prothonotary to list the matter for argument before the first available panel."

Originally, DePhillipo and his wife filed suit against GeneLink and GeneWize, a wholly owned Subsidiary of GeneLink, claiming they were induced to settle an Atlantic County, N.J. law suit by fraud. The complaint alleged that GeneLink's attorney made false representations to John DePhillipo, his lawyer and the trial judge relative to the alleged poor economic well being of GeneLink. ("Defendant GeneLink, Inc. was in such dire financial straits that he didn't know how they were able to pay his attorneys fees.")

Within an hour after the DePhillipos settled the Atlantic County case, GeneLink officers filed a press release revealing, for the first time, the existence of their wholly owned subsidiary, GeneWize. They also added that GeneWize had sold approximately 250 presidential founder memberships for One Thousand ($1000.00) dollars and over 4,000 GeneWize dealerships for Five Hundred ($500.00)

The Common Pleas Court Philadelphia judge dismissed the case ruling that GeneLink's lawyer was only puffing. The appeal to the Superior Court followed.

SOURCE GUSTINE J. PELAGATTI & ASSOCIATES

Back to top
'/>"/>
SOURCE GUSTINE J. PELAGATTI & ASSOCIATES
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. UPDATE: OPC Connectivity Between TruBio Software and Nova FLEX Analyzers
2. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
3. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
4. Update: HYSTA Announces Dr. Qi Lu to Continue on as President of HYSTA, USA
5. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
6. RG Global Corporate Update: First Coal Bed Methane Water Treatment Plant Near Completion; Expanding Water Treatment Applications
7. UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
8. Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
9. Appeal of Lawsuit by Former Officer Dismissed; Request for Sanctions Granted
10. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
11. deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- Research and Markets has announced the addition ... their offering. ... The Global Market for Bioproducts Should Reach $714.6 ... CAGR of 8.9%, This research report quantifies ... major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), ...
(Date:3/23/2017)... -- GlobeImmune, Inc. today announced it has entered into a ... of its common stock to NantCell, Inc., a member ... sale of its common stock, NantCell has agreed to ... 200,000 shares, an estimated $2.0 million in value, of ... to enter into this strategic agreement with NantCell," said ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... Colo. , March 23, 2017  Agriculture technology ... Series A financing and note conversion to commercialize its ... Planet is focused on developing products that are simultaneously ... $30 million in the last 18 months. This latest ... North Bridge Venture Partners. The company,s ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Who risk to ... Download the full report: https://www.reportbuyer.com/product/4313699/ ... FINGERPRINT SENSOR FIELD? Fingerprint sensors using capacitive technology ... fingerprint sensor vendor Idex forecasts an increase of 360% ... devices and of the fingerprint sensor market between 2014 ...
(Date:2/28/2017)... Feb. 28, 2017   Acuant , a leading ... announces significant enhancements to new and core technologies building ... products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity documents ... provides the fastest and most accurate capture software to ...
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
Breaking Biology News(10 mins):